Literature DB >> 19509386

Universal voluntary testing and treatment for prevention of HIV transmission.

Carl W Dieffenbach1, Anthony S Fauci.   

Abstract

Mesh：

Year:  2009        PMID： 19509386     DOI： 10.1001/jama.2009.828

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  137 in total

1.  Antiretroviral adherence and development of drug resistance are the strongest predictors of genital HIV-1 shedding among women initiating treatment.

Authors:  Susan M Graham; Linnet Masese; Ruth Gitau; Zahra Jalalian-Lechak; Barbra A Richardson; Norbert Peshu; Kishor Mandaliya; James N Kiarie; Walter Jaoko; Jeckoniah Ndinya-Achola; Julie Overbaugh; R Scott McClelland
Journal:  J Infect Dis       Date:  2010-10-05       Impact factor: 5.226

2.  Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection.

Authors:  Elizabeth Connick; Ronald J Bosch; Evgenia Aga; Rick Schlichtemeier; Lisa M Demeter; Paul Volberding
Journal:  J Acquir Immune Defic Syndr       Date:  2011-09-01       Impact factor: 3.731

3.  Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention.

Authors:  Michael J Mugavero; K Rivet Amico; Andrew O Westfall; Heidi M Crane; Anne Zinski; James H Willig; Julia C Dombrowski; Wynne E Norton; James L Raper; Mari M Kitahata; Michael S Saag
Journal:  J Acquir Immune Defic Syndr       Date:  2012-01-01       Impact factor: 3.731

4.  Directly observed versus self-administered antiretroviral therapies: preference of HIV-positive jailed inmates in San Francisco.

Authors:  Parya Saberi; Nikolai H Caswell; Ross Jamison; Milton Estes; Jacqueline P Tulsky
Journal:  J Urban Health       Date:  2012-10       Impact factor: 3.671

5.  Operationalizing treatment as prevention in Los Angeles County: antiretroviral therapy use and factors associated with unsuppressed viral load in the Ryan White system of care.

Authors:  Jennifer N Sayles; Jacqueline Rurangirwa; Min Kim; Janni Kinsler; Rangell Oruga; Mike Janson
Journal:  AIDS Patient Care STDS       Date:  2012-07-09       Impact factor: 5.078

6.  Antiretroviral therapy for tuberculosis control in nine African countries.

Authors:  Brian G Williams; Reuben Granich; Kevin M De Cock; Philippe Glaziou; Abhishek Sharma; Christopher Dye
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

7.  Letter to the Editor: Treatment as prevention: are HIV clinic patients interested in starting antiretroviral therapy to decrease HIV transmission?

Authors:  Julia C Dombrowski; Robert D Harrington; Mark Fleming; Matthew R Golden
Journal:  AIDS Patient Care STDS       Date:  2010-11-22       Impact factor: 5.078

8.  Underutilization of the AIDS Drug Assistance Program: associated factors and policy implications.

Authors:  Noah C Godwin; James H Willig; Christa R Nevin; Hui-Yi Lin; Jeroan Allison; Kathy Gaddis; Jennifer Peterson; Michael S Saag; Michael J Mugavero; James L Raper
Journal:  Health Serv Res       Date:  2011-01-06       Impact factor: 3.402

Review 9.  Integrating and Interpreting Findings from the Latest Treatment as Prevention Trials.

Authors:  Marie A Brault; Donna Spiegelman; Salim S Abdool Karim; Sten H Vermund
Journal:  Curr HIV/AIDS Rep       Date:  2020-06       Impact factor: 5.071

Review 10.  Assessing the role of masculinity in the transmission of HIV: a systematic review to inform HIV risk reduction counseling interventions for men who have sex with men.

Authors:  Robert J Zeglin
Journal:  Arch Sex Behav       Date:  2015-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.